LACEY WELLER: Open Payments
NPI 1275973638 · CHARLTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| ABBVIE INC. | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Novo Nordisk Inc | 2 | $50 |
| PFIZER INC. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Optinose US, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: Veozah, AIRSUPRA, UBRELVY, LAGEVRIO, JARDIANCE, Wegovy, Xhance, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
